|
End-of-day quote
Shanghai S.E.
2026-09-07
|
5-day change | 1st Jan Change | ||
| 3.720 CNY | -0.27% |
|
-10.79% | -6.53% |
| Market Cap | 2.92B 435M 374M 352M 321M 600M 41.11B 602M 4.17B 1.61B 21.05B 1.63B 1.6B 67.06B | P/E 2024 |
-8.86x | P/E 2025 | -9.48x |
|---|---|---|---|---|---|
| Enterprise Value | 3.14B 467M 402M 378M 345M 645M 44.17B 647M 4.48B 1.73B 22.62B 1.75B 1.72B 72.05B | EV / Sales 2024 |
1.48x | EV / Sales 2025 | 1.79x |
| Free-Float |
68.56% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.27% | ||
| 1 week | -10.79% | ||
| Current month | -8.60% | ||
| 1 month | +5.38% | ||
| 3 months | +7.83% | ||
| 6 months | -7.23% | ||
| Current year | -6.53% |
| 1 week | 3.68 |  | 4.18 |
| 1 month | 3.66 | | 4.45 |
| Current year | 2.85 | | 5.27 |
| 1 year | 2.85 | | 5.27 |
| 3 years | 2.76 | | 6.15 |
| 5 years | 2.76 | | 8.8 |
| 10 years | 2.76 | | 20.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 42 | 2021-05-12 |
Xianti Zeng
DFI | Director of Finance/CFO | 52 | 2024-09-05 |
Zhi Wei Wang
PRN | Corporate Officer/Principal | 56 | 2019-09-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Ling Dou
CHM | Chairman | 66 | 2009-01-21 |
Zhi Wei Wang
BRD | Director/Board Member | 56 | 2011-02-20 |
Ya Qi Dou
BRD | Director/Board Member | 42 | 2019-01-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.27% | -10.79% | -14.29% | -31.62% | 436M | |
| -0.88% | -2.15% | +58.05% | +105.26% | 1,024B | |
| -1.15% | +2.68% | +54.25% | +74.19% | 663B | |
| -1.44% | +0.38% | +20.65% | +76.13% | 453B | |
| -0.95% | +0.23% | +30.91% | +37.78% | 352B | |
| -3.18% | +1.78% | +22.62% | +41.55% | 304B | |
| +0.30% | +0.67% | +0.60% | +11.25% | 252B | |
| -1.55% | +1.11% | +54.15% | +75.59% | 236B | |
| +0.02% | +2.24% | -13.83% | -55.80% | 206B | |
| -0.15% | +3.65% | +31.24% | +103.39% | 187B | |
| Average | -0.91% | +0.10% | +24.44% | +43.77% | 367.88B | |
| Weighted average by Cap. | -1.04% | +0.62% | +37.66% | +66.89% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.17B 324M 279M 262M 239M 447M 30.63B 449M 3.11B 1.2B 15.69B 1.22B 1.19B 49.97B | 1.86B 278M 239M 224M 205M 383M 26.25B 385M 2.66B 1.03B 13.44B 1.04B 1.02B 42.82B |
| Net income | -317M -47.26M -40.64M -38.23M -34.9M -65.26M -4.47B -65.47M -453M -175M -2.29B -177M -174M -7.29B | -330M -49.1M -42.23M -39.71M -36.25M -67.8M -4.64B -68.02M -471M -182M -2.38B -184M -180M -7.57B |
| Net Debt | 411M 61.22M 52.65M 49.51M 45.2M 84.53M 5.79B 84.81M 587M 227M 2.96B 230M 225M 9.44B | 217M 32.35M 27.82M 26.16M 23.88M 44.67M 3.06B 44.81M 310M 120M 1.57B 121M 119M 4.99B |
Employees
4,832
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-06 | CN¥3.720 | -0.27% | 25,077,630 |
| 26-09-04 | CN¥3.730 | -1.58% | 39,356,153 |
| 26-09-03 | CN¥3.790 | -4.53% | 50,850,104 |
| 26-09-02 | CN¥3.970 | -4.34% | 57,139,109 |
| 26-09-01 | CN¥4.150 | +1.97% | 73,218,400 |
- Stock Market
- Stocks
- 600594 Stock
Select your edition
All financial news and data tailored to specific country editions
